SynTelus, a CSE Life Science Company focusing on end-use fungicides, insecticides and herbicides, as brought on Jeffery Pritchard as President and Chief Operating Officer.  Pritchard will be responsible for strategic direction, sales and marketing, and managing operational and supply chain endeavors.

Pritchard has a long history of leadership roles within both post-patent and R&D based crop-protection companies, most recently as President, North America, for Sharda USA. Previously he led UPI in the United States. Prior to joining UPI, Pritchard worked at American Cyanamid for more than 15 years in various commercial and leadership capacities, last serving as President of Latin America South, residing in Buenos Aires, Argentina.

“Jeff and I have known each other for years, at times as competitors and at times as customers of each other,” said Randy Canady, founder and CEO of SynTelus and its parent company CSE Life Science Holdings. “We feel fortunate to bring Jeff on board as an equity partner in SynTelus. We’re looking forward to the growth that his knowledge, leadership and business philosophy will drive.”

“This is a very exciting time in US agriculture, and I look forward to working with Randy and the entire SynTelus team,” said Pritchard. “The market is ripe for a customer-centric, market-driven supplier of post-patent and differentiated chemistries. Our development initiatives will focus on technology and market opportunities delivered through a seamless channel model that is sustainable and profitable for SynTelus and the customers we serve.”